VectivBio Holding AG
VECT · NASDAQ
12/31/2022 | 6/30/2022 | 12/31/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $382 | $238 | $132 | $314 |
| - Cash | $221 | $142 | $103 | $145 |
| + Debt | $10 | $0 | $0 | $0 |
| Enterprise Value | $171 | $96 | $30 | $170 |
| Revenue | $1 | $27 | $0 | $0 |
| % Growth | -97.5% | – | – | – |
| Gross Profit | $1 | $27 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$29 | -$51 | -$43 | -$43 |
| % Margin | -4,236.8% | -192% | – | – |
| Net Income | -$28 | -$65 | -$44 | -$44 |
| % Margin | -4,212.8% | -244.7% | – | – |
| EPS Diluted | -0.65 | -1.47 | -1.62 | -1.62 |
| % Growth | 55.8% | 9.3% | 0% | – |
| Operating Cash Flow | $54 | -$110 | -$36 | -$36 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $54 | -$110 | -$36 | -$36 |